Local Institution - 0008

Nashville, Tennessee 37232-6307

1 studies enrolling now · 3 studies all time

What they study most

Brain Neoplasms, Relapsed and/or Refractory Multiple Myeloma, Stage IV or Recurrent Non-Small Cell Lung Cancer

Studies at this site

• A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma — Recruiting now
• An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) — Completed
• An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) — Completed